Combination monoclonal antibody

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W911QY21D0012
Awardee
Awarding agency
Task orders
3 $1,829,200,064 obligated

Award facts

Combined order value
$1,829,200,064 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 75% used
$2,437,500,000.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Eli Lilly and Company a single award, indefinite delivery contract with a potential value of $2.4 billion to procure monoclonal antibody treatments. Three firm fixed price delivery orders have been issued against this contract vehicle to date, totaling over $1.8 billion, to supply monoclonal antibody products in support of the national interest action code for Coronavirus COVID-19.

The initial delivery order awarded in September 2021 was valued at $329.8 million to provide 388,000 doses of monoclonal antibody LY-CoV016 for performance at Eli Lilly's Indianapolis, Indiana facilities between mid-September through early November 2021. In November 2021, two additional delivery orders valued at $1.29 billion and $210 million respectively were issued for a total of 712,000 doses of combination monoclonal antibody with performance in Indianapolis scheduled through December 2022.

These monoclonal antibody treatments are being acquired by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense, which supports the Department of Defense's medical response efforts for chemical and biological defense programs, including addressing needs stemming from the ongoing COVID-19 public health emergency. No set aside designations were applied under the contract.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00009 · Covid-19 combination monoclonal antibody $0
Other Administrative Action P00008 $0
Other Administrative Action P00007 · Covid-19: update delivery date for clins 0001 and 0002 from 31 january 22 to 30 june 22 $0
Supplemental Agreement for work within scope P00006 · Under the authority of JA-22-jcrd-008, this modification will 1) increase the total ceiling quantity of the combined monoclonal anitibody by 250,000 doses and… $0
Change Order P00005 · Covid-19 modification to update section h.9 and h.11. Also, modifying dose ceiling amounts per clin. Total dose ceiling remains 1.2 million. $0
Other Administrative Action P00004 · Covid-19:modification to update section h.9 and remove hrpas rating from this contract. $0
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Other Administrative Action P00001 · Combination monoclonal antibody - modification to add rating to IDIQ $0
Original award $0

Quick answers

Who was awarded contract W911QY21D0012?

W911QY21D0012 was awarded to ELI Lilly And Company by ACC Aberdeen Proving Ground (Army Contracting Command) on February 25, 2021.

How much is contract W911QY21D0012 worth?

Orders under W911QY21D0012 have obligated $1,829,200,064. W911QY21D0012's own ceiling is $2,437,500,000.

How many orders have been placed under contract W911QY21D0012?

3 orders have been placed under W911QY21D0012, the latest on November 1, 2021.

Which agency awarded contract W911QY21D0012?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY21D0012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Who can order from contract W911QY21D0012?

W911QY21D0012 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W911QY21D0012 competed?

The extent of competition for W911QY21D0012 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV